Shropshire, United Kingdom

Stephen Gordon Douglas

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 136(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Stephen Gordon Douglas

Introduction

Stephen Gordon Douglas is a notable inventor based in Shropshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of arthritis. With a total of 2 patents, Douglas has focused on creating effective medicinal compositions that combine non-steroidal anti-inflammatory drugs with opioid analgesics.

Latest Patents

Douglas's latest patents include a synergistic composition of codeine and ibuprofen to treat arthritis. This invention relates to the use of a non-steroidal anti-inflammatory drug together with an opioid analgesic in the manufacture of a medicament for the treatment of arthritis. Another patent he holds is for pharmaceutical compositions and usages, which also focuses on the combination of these two types of medications for arthritis treatment.

Career Highlights

Stephen Gordon Douglas is currently associated with Euro-Celtique S.A., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new treatment options for patients suffering from arthritis, showcasing his commitment to improving healthcare.

Collaborations

Douglas has collaborated with notable individuals in his field, including Ronald Brown Miller and Allan John Miller. These partnerships have likely contributed to the success of his inventions and the advancement of pharmaceutical research.

Conclusion

Stephen Gordon Douglas exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through his patents and collaborations highlight the importance of combining different therapeutic approaches to enhance patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…